To print: Select File and then Print from your browser's menu --------------------------------------------------------------------------------------- Title: FDA Approves Depakote (Divalproex) Extended Release For Migraine Prevention URL: http://www.pslgroup.com/dg/1E43B2.htm Doctor's Guide October 13, 2000
NEW YORK, NY -- October 13, 2000 -- The FDA recently approved Depakote ER (divalproex sodium extended-release tablets), a once-a-day formulation for the prevention of migraine headaches in adults. Developed by Abbott Laboratories, Depakote ER is currently available by prescription in the U.S. An estimated 28 million Americans suffer from migraines. Migraines can be debilitating, and can disrupt daily activities and job performance. Statistics show migraine sufferers miss 157 million workdays every year at a cost of as much as 17 billion dollars to the U.S. economy. By taking Depakote ER just once a day, frequent migraine sufferers can prevent migraines before they start, and enjoy their lives again. Related links: Depakote and Abbott Laboratories. --------------------------------------------------------------------------------------------- Copyright © 1999 P\S\L Consulting Group Inc. All rights reserved. Republication or redistribution of P\S\L content is expressly prohibited without the prior written consent of P\S\L. P\S\L shall not be liable for any errors, omissions or delays in this content or any other content on its sites, newsletters or other publications, nor for any decisions or actions taken in reliance on such content. --------------------------------------------------------------------------------------------- This news story was printed from *Doctor's Guide to the Internet* located at http://www.docguide.com --------------------------------------------------------------------------------------- Return to News Story Page This site is maintained by webmaster@pslgroup.com Please contact us with any comments, problems or bugs. All contents Copyright (c) 1998 P\S\L Consulting Group Inc. All rights reserved.